Temporal lobe epilepsy: Correlation of proton magnetic resonance spectroscopy and 18F-fluorodeoxyglucose positron emission tomography

Proton magnetic resonance spectroscopy (MRS) has demonstrated reduction of N‐acetylaspartate (NAA) in the epileptogenic temporal lobe. However, the correlation of NAA reduction with cerebral metabolic abnormalities is unknown in temporal lobe epilepsy (TLE). Proton MRS and 18F‐fluorodeoxyglucose pos...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Magnetic resonance in medicine 1997-01, Vol.37 (1), p.18-23
Hauptverfasser: Lu, Dongfeng, Margouleff, Claude, Rubin, Eric, Labar, Douglas, Schaul, Neil, Ishikawa, Tatsuya, Kazumata, Ken, Antonini, Angelo, Dhawan, Vijay, Hyman, Roger A., Eidelberg, David
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Proton magnetic resonance spectroscopy (MRS) has demonstrated reduction of N‐acetylaspartate (NAA) in the epileptogenic temporal lobe. However, the correlation of NAA reduction with cerebral metabolic abnormalities is unknown in temporal lobe epilepsy (TLE). Proton MRS and 18F‐fluorodeoxyglucose positron emission tomography (FDG/PET) were used to study 12 unilateral TLE patients with medically intractable seizures and 26 age‐matched healthy volunteers. The epileptogenic temporal lobe of each patient was determined by both electroencephalography and FDG/PET. The NAA/choline‐plus‐creatine (NAA/(Cho+Cr)) ratio correlated significantly with the interictal glucose metabolism (r = 0.54, P 0.01) in 12 TLE patients. The mean NAA/(Cho + Cr) ratio in the epileptogenic temporal lobe was significantly less than that in the contralateral side (P < 0.01), and less than that in normal control temporal lobes (P < 0.0001). These results suggest that quantitative MRS abnormalities reflect underlying metabolic pathology in TLE.
ISSN:0740-3194
1522-2594
DOI:10.1002/mrm.1910370105